Cardiac disorder-related adverse events for aryl hydrocarbon receptor agonists: a safety review-Reference-Cited by-同舟云学术

Cardiac disorder-related adverse events for aryl hydrocarbon receptor agonists: a safety review

Published:2022-05-27 Issue:12 Volume:21 Page:1505-1510
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Tian Xiaoxue¹²³,Zheng Shufen¹²³,Wang Jing²³,Yu Meiling²³,Lin Zhuoheng²³,Qin Min²³,Wu Yuanyuan²³,Chen Shiyu²³,Zhong Shilong¹²³⁴

Affiliation:

1. Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China

2. Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Cardiovascular Institute, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China

3. School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, Guangdong, China

4. Department of Cardiology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2022.2078301

Reference37 articles.

1. The aryl hydrocarbon receptor and the gut–brain axis

2. The Aryl Hydrocarbon Receptor (AHR) as a Potential Target for the Control of Intestinal Inflammation: Insights from an Immune and Bacteria Sensor Receptor

3. Environment-Sensing Aryl Hydrocarbon Receptor Inhibits the Chondrogenic Fate of Modulated Smooth Muscle Cells in Atherosclerotic Lesions

4. AHR Signaling Interacting with Nutritional Factors Regulating the Expression of Markers in Vascular Inflammation and Atherogenesis

5. Host–microbiome interactions: the aryl hydrocarbon receptor as a critical node in tryptophan metabolites to brain signaling

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adverse tumor events induced by ranitidine: an analysis based on the FAERS database;Expert Opinion on Drug Safety;2024-05-21

2. A disproportionality analysis of FDA adverse event reporting system (FAERS) events for ticagrelor;Frontiers in Pharmacology;2024-04-09

3. Drugs associated with a risk of supraventricular tachycardia: analysis using the OpenVigil database;Journal of International Medical Research;2024-03

4. Drug-induced hypoglycemia: a disproportionality analysis of the FAERS database;Expert Opinion on Drug Safety;2023-11

5. Liver injury in children: signal analysis of suspected drugs based on the food and drug administration adverse event reporting system;BMC Pediatrics;2023-09-28